Goodall E, Palmer J, Martynchyk A, Waters N, et al. Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice. Br J Haematol 2026 May 15. doi: 10.1111/bjh.70550.
PMID: 42141736